{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:48:39Z","timestamp":1778798919978,"version":"3.51.4"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Zoledronic acid (ZOL) is a potent antiresorptive agent that increases bone mineral density (BMD) and reduces fracture risk in postmenopausal osteoporosis (PMOP). The anti-osteoporotic effect of ZOL is determined by annual BMD measurement. In most cases, bone turnover markers function as early indicators of therapeutic response, but they fail to reflect long-term effects. We used untargeted metabolomics to characterize time-dependent metabolic shifts in response to ZOL and to screen potential therapeutic markers. In addition, bone marrow RNA-seq was performed to support plasma metabolic profiling. Sixty rats were assigned to sham-operated group (SHAM, n = 21) and ovariectomy group (OVX, n = 39) and received sham operation or bilateral ovariectomy, respectively. After modeling and verification, rats in the OVX group were further divided into normal saline group (NS, n = 15) and ZOL group (ZA, n = 18). Three doses of 100\u00a0\u03bcg\/kg ZOL were administrated to the ZA group every 2\u00a0weeks to simulate 3-year ZOL therapy in PMOP. An equal volume of saline was administered to the SHAM and NS groups. Plasma samples were collected at five time points for metabolic profiling. At the end of the study, selected rats were euthanatized for bone marrow RNA-seq. A total number of 163 compound were identified as differential metabolites between the ZA and NS groups, including mevalonate, a critical molecule in target pathway of ZOL. In addition, prolyl hydroxyproline (PHP), leucyl hydroxyproline (LHP), 4-vinylphenol sulfate (4-VPS) were identified as differential metabolites throughout the study. Moreover, 4-VPS negatively correlated with increased vertebral BMD after ZOL administration as time-series analysis revealed. Bone marrow RNA-seq showed that the PI3K-AKT signaling pathway was significantly associated with ZOL-mediated changes in expression (adjusted-p = 0.018). In conclusion, mevalonate, PHP, LHP, and 4-VPS are candidate therapeutic markers of ZOL. The pharmacological effect of ZOL likely occurs through inhibition of the PI3K-AKT signaling pathway.<\/jats:p>","DOI":"10.3389\/fphar.2023.1084453","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T04:34:31Z","timestamp":1682397271000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Identifying therapeutic biomarkers of zoledronic acid by metabolomics"],"prefix":"10.3389","volume":"14","author":[{"given":"Xiang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhan-Ying","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Wei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie-Mei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen-Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Tian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"110778","DOI":"10.1016\/j.exger.2019.110778","article-title":"The multiple faces of tryptophan in bone biology","volume":"129","author":"Al Saedi","year":"2020","journal-title":"Exp. Gerontol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"14641","DOI":"10.1002\/jcp.28207","article-title":"Wnt signaling pathway in osteoporosis: Epigenetic regulation, interaction with other signaling pathways, and therapeutic promises","volume":"234","author":"Amjadi-Moheb","year":"2019","journal-title":"J. Cell Physiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.3390\/ijms21186670","article-title":"The role of tryptophan metabolites in musculoskeletal stem cell aging","volume":"21","author":"Anaya","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"C1005","DOI":"10.1152\/ajpcell.00520.2019","article-title":"Irradiation-induced senescence of bone marrow mesenchymal stem cells aggravates osteogenic differentiation dysfunction via paracrine signaling","volume":"318","author":"Bai","year":"2020","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3390\/ijms23021005","article-title":"Catabolism of hydroxyproline in vertebrates: Physiology, evolution, genetic diseases and new siRNA approach for treatment","volume":"23","author":"Belostotsky","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/jbmr.1494","article-title":"The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-pivotal fracture trial (PFT)","volume":"27","author":"Black","year":"2012","journal-title":"J. Bone Min. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/jbmr.2442","article-title":"The effect of 6 versus 9 years of zoledronic acid treatment in osteoporosis: A randomized second extension to the HORIZON-pivotal fracture trial (PFT)","volume":"30","author":"Black","year":"2015","journal-title":"J. Bone Min. Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/gl-2020-0524suppl","article-title":"American association of clinical endocrinologists\/American College of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 updata","volume":"26","author":"Camacho","year":"2020","journal-title":"Endocr. Pract."},{"key":"B10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/s8756-3282(98)00081-7","article-title":"Arginine increases insulin-like growth factor-I production and collagen synthesis in osteoblast-like cells","volume":"23","author":"Chevalley","year":"1998","journal-title":"Bone"},{"key":"B11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s12276-018-0134-x","article-title":"PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice","volume":"50","author":"Choi","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/s0140-6736(18)32112-3","article-title":"Osteoporos","volume":"393","author":"Compston","year":"2019","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/s0140-6736(02)08657-9","article-title":"Epidemiology and outcomes of osteoporotic fractures","volume":"359","author":"Cummings","year":"2002","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/s2213-8587(17)30184-5","article-title":"Use of bone turnover markers in postmenopausal osteoporosis","volume":"5","author":"Eastell","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/s0753-3322(01)00054-3","article-title":"Effect of L-lysine and L-arginine on primary osteoblast cultures from normal and osteopenic rats","volume":"55","author":"Fini","year":"2001","journal-title":"Biomed. Pharmacother."},{"key":"B16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00223-020-00687-2","article-title":"Glucocorticoids enhanced osteoclast autophagy through the PI3K\/Akt\/mTOR signaling pathway","volume":"107","author":"Fu","year":"2020","journal-title":"Calcif. Tissue Int."},{"key":"B17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.cell.2018.03.008","article-title":"Pseudouridylation of tRNA-derived fragments steers translational control in stem cells","volume":"173","author":"Guzzi","year":"2018","journal-title":"Cell"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1515\/cclm.2008.259","article-title":"Prolyl-hydroxyproline dipeptide in non-hydrolyzed morning urine and its value in postmenopausal osteoporosis","volume":"46","author":"Husek","year":"2008","journal-title":"Clin. Chem. Lab. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/sj.bjp.0706373","article-title":"The inhibitory effect of alendronate, a nitrogen-containing bisphosphonate on the PI3K-Akt-NFkappaB pathway in osteosarcoma cells","volume":"146","author":"Inoue","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1002\/jsfa.7606","article-title":"Ingestion of bioactive collagen hydrolysates enhance facial skin moisture and elasticity and reduce facial ageing signs in a randomised double-blind placebo-controlled clinical study","volume":"96","author":"Inoue","year":"2016","journal-title":"J. Sci. Food Agric."},{"key":"B22","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.mcna.2020.06.004","article-title":"Osteoporosis in older adults","volume":"104","author":"Johnston","year":"2020","journal-title":"Med. Clin. North Am."},{"key":"B23","doi-asserted-by":"publisher","first-page":"665","DOI":"10.7326\/0003-4819-76-4-665_2","article-title":"Calcitonin in the treatment of Paget's disease of bone","volume":"76","author":"Johnston","year":"1972","journal-title":"Ann. Intern Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"12901","DOI":"10.1073\/pnas.1001499107","article-title":"Important roles of PI3Kgamma in osteoclastogenesis and bone homeostasis","volume":"107","author":"Kang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B25","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.bbrc.2014.09.121","article-title":"Collagen-derived dipeptide prolyl-hydroxyproline promotes differentiation of MC3T3-E1 osteoblastic cells","volume":"453","author":"Kimira","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s11658-017-0060-2","article-title":"Collagen-derived dipeptide prolyl-hydroxyproline promotes osteogenic differentiation through Foxg1","volume":"22","author":"Kimira","year":"2017","journal-title":"Cell Mol. Biol. Lett."},{"key":"B27","doi-asserted-by":"publisher","first-page":"115836","DOI":"10.1016\/j.bone.2020.115836","article-title":"Glutamine metabolite \u03b1-ketoglutarate acts as an epigenetic co-factor to interfere with osteoclast differentiation","volume":"145","author":"Lee","year":"2021","journal-title":"Bone"},{"key":"B28","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.cbpa.2016.06.014","article-title":"Pseudouridine: The fifth RNA nucleotide with renewed interests","volume":"33","author":"Li","year":"2016","journal-title":"Curr. Opin. Chem. Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"7417","DOI":"10.1111\/jcmm.15357","article-title":"CMap analysis identifies Atractyloside as a potential drug candidate for type 2 diabetes based on integration of metabolomics and transcriptomics","volume":"24","author":"Li","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s10735-021-10006-0","article-title":"Prednisolone induces osteocytes apoptosis by promoting Notum expression and inhibiting PI3K\/AKT\/GSK3\u03b2\/\u03b2-catenin pathway","volume":"52","author":"Li","year":"2021","journal-title":"J. Mol. Histol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"6661534","DOI":"10.1155\/2021\/6661534","article-title":"Zoledronic acid enhanced the antitumor effect of cisplatin on orthotopic osteosarcoma by ROS-PI3K\/AKT signaling and attenuated osteolysis","volume":"2021","author":"Liu","year":"2021","journal-title":"Oxid. Med. Cell Longev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00198-021-06084-1","article-title":"Heavy clinical and economic burden of osteoporotic fracture among elderly female Medicare beneficiaries","volume":"33","author":"Liu","year":"2022","journal-title":"Osteoporos. Int."},{"key":"B33","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.tiv.2008.01.006","article-title":"Preclinical evidence for nitrogen-containing bisphosphonate inhibition of farnesyl diphosphate (FPP) synthase in the kidney: Implications for renal safety","volume":"22","author":"L\u00fche","year":"2008","journal-title":"Toxicol Vitro"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1021\/acs.jproteome.1c00167","article-title":"Integration of metabolomics and transcriptomics reveals ketone body and lipid metabolism disturbance related to ER stress in the liver","volume":"20","author":"Ma","year":"2021","journal-title":"J. Proteome Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e1003012","DOI":"10.1371\/journal.pmed.1003012","article-title":"Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in alzheimer disease: A targeted metabolomic and transcriptomic study","volume":"17","author":"Mahajan","year":"2020","journal-title":"PLoS Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/s0378-4274(02)00190-x","article-title":"GSTM1 polymorphism and styrene metabolism: Insights from an acute accidental exposure","volume":"134","author":"Manini","year":"2002","journal-title":"Toxicol. Lett."},{"key":"B37","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/s0041-008x(03)00124-8","article-title":"Assessment of biotransformation of the arene moiety of styrene in volunteers and occupationally exposed workers","volume":"189","author":"Manini","year":"2003","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s11914-012-0109-0","article-title":"Signaling pathways affecting skeletal health","volume":"10","author":"Marie","year":"2012","journal-title":"Curr. Osteoporos. Rep."},{"key":"B39","doi-asserted-by":"publisher","first-page":"103111","DOI":"10.1016\/j.ebiom.2020.103111","article-title":"Association between the metabolome and bone mineral density in a Chinese population","volume":"62","author":"Mei","year":"2020","journal-title":"EBioMedicine"},{"key":"B40","first-page":"779","article-title":"New insights into tryptophan and its metabolites in the regulation of bone metabolism","volume":"66","author":"Michalowska","year":"2015","journal-title":"J. Physiol. Pharmacol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/jbmr.3358","article-title":"Metabolomic pathways to osteoporosis in middle-aged women: A genome-metabolome-wide mendelian randomization study","volume":"33","author":"Moayyeri","year":"2018","journal-title":"J. Bone Min. Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4049\/jimmunol.1101254","article-title":"Akt induces osteoclast differentiation through regulating the GSK3\u03b2\/NFATc1 signaling cascade","volume":"188","author":"Moon","year":"2012","journal-title":"J. Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1038\/sj.emboj.7601317","article-title":"Secretion of L-glutamate from osteoclasts through transcytosis","volume":"25","author":"Morimoto","year":"2006","journal-title":"Embo J."},{"key":"B44","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrrheum.2012.86","article-title":"Bone turnover markers: Use in osteoporosis","volume":"8","author":"Naylor","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/4551054a","article-title":"Systems biology: Metabonomics","volume":"455","author":"Nicholson","year":"2008","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1080\/09168451.2019.1642099","article-title":"Collagen-derived dipeptide prolyl hydroxyproline directly binds to Foxg1 to change its conformation and inhibit the interaction with Runx2","volume":"83","author":"Nomura","year":"2019","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1042\/bsr20210304","article-title":"Stimulation of the Runx2 P1 promoter by collagen-derived dipeptide prolyl-hydroxyproline bound to Foxg1 and Foxo1 in osteoblasts","volume":"41","author":"Nomura","year":"2021","journal-title":"Biosci. Rep."},{"key":"B48","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1093\/hmg\/ddt430","article-title":"Epigenetics meets metabolomics: An epigenome-wide association study with blood serum metabolic traits","volume":"23","author":"Petersen","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/s0140-6736(10)62349-5","article-title":"Osteoporosis: Now and the future","volume":"377","author":"Rachner","year":"2011","journal-title":"Lancet"},{"key":"B50","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11926-003-0085-6","article-title":"Bisphosphonate mechanism of action","volume":"5","author":"Reszka","year":"2003","journal-title":"Curr. Rheumatol. Rep."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e12423","DOI":"10.1111\/jpi.12423","article-title":"Regulation of bone mass through pineal-derived melatonin-MT2 receptor pathway","volume":"63","author":"Sharan","year":"2017","journal-title":"J. Pineal Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2020.05.032","article-title":"Proteomic and metabolomic characterization of COVID-19 patient sera","volume":"182","author":"Shen","year":"2020","journal-title":"Cell"},{"key":"B53","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1423-0127-21-10","article-title":"Nitrogen-containing bisphosphonates inhibit RANKL- and M-CSF-induced osteoclast formation through the inhibition of ERK1\/2 and Akt activation","volume":"21","author":"Tsubaki","year":"2014","journal-title":"J. Biomed. Sci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0306-9877(94)90113-9","article-title":"Arginine supplementation in the prevention and treatment of osteoporosis","volume":"43","author":"Visser","year":"1994","journal-title":"Med. Hypotheses"},{"key":"B55","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/tpj.2014.52","article-title":"Genetic polymorphisms in the mevalonate pathway affect the therapeutic response to alendronate treatment in postmenopausal Chinese women with low bone mineral density","volume":"15","author":"Wang","year":"2015","journal-title":"Pharmacogenomics J."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00198-019-04892-0","article-title":"Discovery of potential biomarkers for osteoporosis using LC-MS\/MS metabolomic methods","volume":"30","author":"Wang","year":"2019","journal-title":"Osteoporos. Int."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e2121106","DOI":"10.1001\/jamanetworkopen.2021.21106","article-title":"Prevalence of osteoporosis and fracture in China: The China osteoporosis prevalence study","volume":"4","author":"Wang","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"B58","doi-asserted-by":"publisher","first-page":"695480","DOI":"10.3389\/fcvm.2021.695480","article-title":"Using a two-sample mendelian randomization method in assessing the causal relationships between human blood metabolites and heart failure","volume":"8","author":"Wang","year":"2021","journal-title":"Front. Cardiovasc Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"112595","DOI":"10.1016\/j.yexcr.2021.112595","article-title":"Glucocorticoids suppressed osteoblast differentiation by decreasing Sema3A expression via the PIK3\/Akt pathway","volume":"403","author":"Xing","year":"2021","journal-title":"Exp. Cell Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s13577-020-00352-8","article-title":"miR-140-3p aggregates osteoporosis by targeting PTEN and activating PTEN\/PI3K\/AKT signaling pathway","volume":"33","author":"Yin","year":"2020","journal-title":"Hum. Cell"},{"key":"B61","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/jbmr.2018","article-title":"Association between the metabolome and low bone mineral density in Taiwanese women determined by (1)H NMR spectroscopy","volume":"29","author":"You","year":"2014","journal-title":"J. Bone Min. Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"e13194","DOI":"10.1111\/cpr.13194","article-title":"Gut microbiota modulates osteoclast glutathione synthesis and mitochondrial biogenesis in mice subjected to ovariectomy","volume":"55","author":"Yuan","year":"2022","journal-title":"Cell Prolif."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1007\/s00784-015-1706-y","article-title":"Effects of zoledronic acid and geranylgeraniol on the cellular behaviour and gene expression of primary human alveolar osteoblasts","volume":"20","author":"Zafar","year":"2016","journal-title":"Clin. Oral Investig."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1084453\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T04:34:39Z","timestamp":1682397279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1084453\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":63,"alternative-id":["10.3389\/fphar.2023.1084453"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1084453","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,25]]},"article-number":"1084453"}}